| Nov 2 |
Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
|
| Nov 1 |
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)
|
| Oct 31 |
Q3 2024 Bio Rad Laboratories Inc Earnings Call
|
| Oct 31 |
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
|
| Oct 31 |
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket
|
| Oct 31 |
Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...
|
| Oct 31 |
Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates
|
| Oct 30 |
Bio-Rad: Q3 Earnings Snapshot
|
| Oct 30 |
Bio-Rad Reports Third-Quarter 2024 Financial Results
|
